États-Unis · Plateformes & données · Finviz

Kura Oncology to Report Third Quarter Financial Results on November 10

Publié par Finviz · États-Unis il y a 9 h

Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced it will report its third quarter 2026…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

Kura Oncology to Report Third Quarter Financial Results on November 10

À lire aussi

Revvity rises on full-year guidance boost

Warren Buffett Has 1 Simple Rule for Investing During Bear Markets. History Says He's Right.

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

5 questions to ask if your boss offers you a buyout, as Microsoft did with 60,000 employees

US job openings increase sharply in September

Kura Oncology to Report Third Quarter Financial Results on November 10

Partager

À lire aussi

Revvity rises on full-year guidance boost

Warren Buffett Has 1 Simple Rule for Investing During Bear Markets. History Says He's Right.

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

5 questions to ask if your boss offers you a buyout, as Microsoft did with 60,000 employees

US job openings increase sharply in September